Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis -oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance

By sjmartinez • March 7, 2023

Mishra NN, Abdelhady W, Elsayed AM, Lapitan C, Proctor RA, Rybak MJ, Miro JM, Bayer AS. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance. Antimicrob Agents Chemother. 2023 Mar 6:e0147222. doi: 10.1128/aac.01472-22. Epub ahead of print. PMID: 36877026.

Tags: ceftriaxone, daptomycin, endocarditis, Harbor UCLA, Infectious Diseases, Publications, S. mitis-oralis

Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia

Bergersen KV, Zheng Y, Rossetti M, Ruffin F, Pickering H, Parmar R, Sunga G, Chan LC, Gjertson D, Fowler VG, Yeaman MR, Reed EF; MRSA[...]

The history and future of online hemodiafiltration and online solutions in North America

Leduc C, Tomisawa N, Ronco C, Kalantar-Zadeh K. The history and future of online hemodiafiltration and online solutions in North America. Curr Opin Nephrol Hypertens.[...]

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial

Luetkemeyer AF, Chew KW, Lacey S, Hughes MD, Harrison LJ, Daar ES, Eron J, Fletcher CV, Greninger AL, Hessinger D, Li JZ, Mailhot D, Wohl[...]